核因子κB在精氨酸血管升压素诱导大鼠心肌成纤维细胞一氧化氮合成中的作用

本文探讨了精氨酸血管升压素(AVP)刺激下体外培养的大鼠心肌成纤维细胞(CFs)内一氧化氮(NO)含量、一氧化氮合酶(NOS)活性、诱导型一氧化氮合酶基因表达的变化及其与核因子κB(NF-κB)的关系。用胰酶消化法分离培养Sprague Dawley仔鼠的CFs,分别采用硝酸还原酶法、分光光度法、逆转录-聚合酶链式反应(RT-PCR)、免疫荧光-共聚焦显微镜和蛋白质印迹检测AVP干预下CFs的NO含量、NOS活性、iNOS mRNA表达和NF-κB的活化。结果显示,AVP浓度依赖性(0．001—0．1μmol／L)地增加CFs的NO含量,提高NOS活性,增加iNOS mRNA表达;AVP能够活化NF—κB,使其由细胞浆转位于细胞核;NF-κB特异性抑制剂吡咯啉烷二甲基硫脲(PDTC)能够抑制AVP诱导的CFs NO含量增加、NOS活性提高和iNOS mRNA表达增加。上述结果提示,AVP干预下CFs iNOS mRNA表达增加、NOS活性增高、NO合成增多可能通过NF-κB激活途径,NF-κB激活参与心肌纤维化的发生和发展。     

尾加压素Ⅱ对人脐静脉内皮细胞iNOS表达的影响

目的：探讨尾加压素Ⅱ（UⅡ）对人脐静脉内皮细胞（HUVEC）诱导型一氧化氮舍酶（iNOS）mRNA表达及一氧化氮（NO）合成的影响。方法：用不同浓度的UⅡ（10^-9～10^-7mol／L）干预体外培养的HUVEC,用硝酸酶还原法及比色法检测细胞培养上清液中NO的水平及iNOS的活性,半定量逆转录一聚合酶联反应（RT—PCR）法检测内皮细胞iNOSmRNA的表达。结果：UⅡ干预24h后,与空白对照组相比,UⅡ呈浓度依赖性显著刺激NO的合成（P〈0．05）,增加iNOS的活性（P〈0．05）,上调iNOSmRNA的表达（P〈0．05）。结论：UⅡ能刺激HUVEC的iN—OSmRNA的表达和NO的合成,提示UⅡ可能通过激活iNOS／NO途径而发挥舒张血管的作用。     

白细胞介素—10对血管一氧化氮／一氧化氮合酶系统的影响

为探讨抗炎因子－－白细胞介素－10（IL－10）对大鼠主动脉一氧化氮（NO）／一氧化氮合酶（NOS）系统的影响,应用Griess试剂、^3H－瓜氨酸生成及蛋白免疫印迹杂交等方法,测定IL－10孵育对血管NO释放、NOS活性及表达的影响。结果发现细菌脂多糖（LPS）呈浓度领带性地激活诱导型NOS（iNOS）,促进NO生成。IL－10（10^-10-10^-8g/ml）呈浓度依赖性地上调内皮型NOS（eNOS）蛋白表达及其活性,但对iNOS活性及表达无明显影响,IL－10（10^-9-10^-8g/ml）显著抑制10μg/ml LPS诱导的NO生成和iNOS激活;而高浓度IL－10（10^-7g/ml）则上调iNOS的活性,对eNOS蛋白的表达知活性无明显影响。因此IL－10对NO／NOS系统具有双重影响,一方面可抑制炎症介质诱发的作为炎性物质的iNOS的表达及激活,另一方面可上调内皮源扩血管物质NO的释放。     

奥帕曲拉对内皮素-1诱导的心脏成纤维细胞增殖的影响

目的：探讨奥帕曲拉（omapatrilat,OMA）对内皮素-1（ET-1）诱导的心脏成纤维细胞（CFs）增殖的干预作用及可能机制．方法：经差速贴壁法培养的新生大鼠CFs,随机分为7组：对照组,ET-1组,OMA组,ET-1＋OMA10^-9mol／L组,ET-1＋OMA10^-8mol／L,ET-1＋OMA10^-7mol／L组．ET-1＋OMA10^-6mol／L组.采用四氮唑盐（MTT）比色法测定CFs数目,流式细胞分析仪（FCM）检测CFs细胞周期,液体闪烁计数仪测定CFs^3H-脯氨酸掺入率,硝酸还原酶法测定细胞培养上清液中NO含量：结果：与对照组相比,10^-7mol／LET-1能显著增加CFs的吸光度A190值及[^3H]-Pro掺入率,降低CFs生成NO的量（均P〈0．01）,10^-9-10^-6mol／L OMA呈浓度依赖性的降低ET-1诱导的A190值和[^3H]—Pro掺入率升高（均P〈0．01）,促进CFsNO的生成（均P〈0．05）;细胞周期分析表明ET—1能显著提高S期细胞百分率（P〈0．01）,10^-7mol／LOMA抑制ET-1诱导S期细胞百分率上升（P〈0．01）.结论：OMA对ET-1诱导的CFs增殖及胶原合成有抑制作用,该作用可能和NO生成有关.     

渗透压对血管内皮细胞中NO合成酶活性的影响及其机制研究

目的：研究非等渗压浓度对血管内皮细胞NO合成酶活性的影响,并探索其发生机制。方法：使血管内皮细胞暴露于低渗（205mOsm)或高渗透压（410mOsm)培养液,用Griess法测定NO合成酶（NOS）活性,以Northern blot ting观测细胞iNOS和eNOS基因表达的变化。结果： 非等渗压浓度可使血管内皮细胞中NOS活性显著升高。细胞NOS活性变化具有明显的时间效应规律,低渗透压浓度效应产生的效应早于高渗透压浓度,且低渗透压浓度的影响较高渗透压浓度更为明显。Dexamethasone对这种非等渗透压诱导的NOS活性没有明显作用,给予cycloheximide,不影响非等渗压诱导的这种差异。Nothern blot分析表明：非等渗压浓度不诱导iNOS基因表达,而使eNOSmRNA表达增加。结论：非等渗透压浓度诱导血管内皮细胞NOS活性升高,eNOS基因表达增强是其主要机制之一。     

盐敏感性高血压大鼠eNOS、iNOS表达与心肌细胞凋亡关系分析

目的探讨盐敏感性高血压形成和心肌细胞损害产生的机制。方法以辣椒辣索损伤Wistar大鼠感觉神经,饲喂高盐饲料,建立盐敏感性高血压大鼠模型。苏木素～伊红染色观察大鼠组织病理学改变;分光光度法检测心肌组织iNOS活性和NO含量;免疫组织化学方法检测心肌eNOS、iNOS蛋白表达;RT．PCR检测心肌eNOS、iNOSmRNA的表达。单细胞凝胶电泳检测心肌细胞凋亡。结果实验结束时各组比较体重无显著性差异（P〉0．05）。在第2、3、4周时,辣椒辣素高盐组鼠尾收缩压与对照组相比差异显著（P〈0．05）。辣椒辣素高盐组心肌细胞排列紊乱、细胞间隙明显增大,细胞核排列不整齐;心肌iNOS、NO水平升高（P〈0．05）;eNOS蛋白表达减少（P〈0．05）与eNOSmRNA表达减少（P〈0．01）;iNOS蛋白表达和iNOSmRNA表达显著增高（P〈0．01）;凋亡细胞数升高（P〈0．05）。结论eNOSmRNA和蛋白的低表达与感觉神经损伤性盐敏感性高血压大鼠形成相关。iNOSmRNA和蛋白的高表达及iNOS活性升高使心肌组织局部产生大量NO。NO可能使得感觉神经损伤性盐敏感性高血压大鼠心肌细胞凋亡增加,从而加重心肌的损伤。     

丹参注射液对庆大霉素耳中毒豚鼠耳蜗NOS异构体表达的影响

目的：研究丹参注射液（SM）对庆大霉素（GM）耳中毒豚鼠耳蜗一氧化氮合酶（NOS）异构体表达的影响,探讨SM对GM耳毒性的防护机制。方法：40只豚鼠随机分成对照组、GM组、SM组和GM＋SM组,应用SABC免疫组织化学方法及显微图像分析技术,观察NOS三型异构体在豚鼠耳蜗的表达;同时结合听脑干反应（ABR）测试,观察用药前后豚鼠听阈的变化。结果：GM＋SM组豚鼠耳蜗诱导型NOS（iNOS/NOSⅡ）表达和ABR阈值均明显低于GM组（P〈0.01）;且iNOS表达变化与ABR阈值改变高度相关（｜r｜〉0.7,P〈0.01）;而各组豚鼠耳蜗神经元型NOS（nNOS/NOSⅠ）和内皮型NOS（eNOS/NOSⅢ）表达均无显著性差异。结论：SM对GM耳中毒后豚鼠耳蜗nNOS和eNOS表达无影响,但可通过抑制GM所致iNOS高表达,以减少NO的过量生成,从而对GM的耳毒性损伤发挥防护作用。     

肢体缺血预适应的肝保护作用与一氧化氮／内皮素-1系统关系的研究

目的：观察肢体缺血／再灌注（I／R）后一氧化氮／内皮素-1（NO／ET-1）失衡与肝损伤的关系以及缺血预适应（1pc）对NO／ET-1系统的调节作用。方法：实验用雄性Wistar大鼠18只,随机分为3组（n=6）：对照组（control）、缺血／再灌注组（I／R）和缺血预适应组（IPC＋I／R）,分别测定血浆谷草转氨酶（ALT）、谷丙转氨酶（AST）;血浆和肝组织一氧化氮（NO）、内皮素-1（ET-I）的含量变化,一氧化氮／内皮素-1（NO／ET-1）比值及肝组织的总一氧化氮合酶（tNOS）、诱导型一氧化氮合酶（iNOS）、结构型一氧化氮合酶（cNOS）的水平;免疫组化法检测肝组织的诱导型一氧化氮舍酶（iNOS）、内皮型一氧化氮合酶（eNOS）的表达;HE染色,在光学显微镜下观察肝组织的形态学改变。结果：发现肢体再灌注期血浆和肝组织NO、ET-1均明显增加,而NO／ET-1的比值却明显降低,同时血浆ALT、AST升高,光学显微镜下肝细胞、内皮细胞肿胀,肝细胞变性及肝窦淤血,炎性细胞浸润,肝损伤加重,肢体I／R后肝组织iNOS的表达增强,而eNOS（主要为eNOS）的表达减少,伴有总NOS活性增强。说明肢体缺血再灌注后肝组织内皮源的NO产生减少,而非内皮源的NO产生增多;IPC减轻了肢体I／R后引起的NO／ET-1失衡。结论：肢体I／R后肝组织损伤与NO／ET-1失衡有关,IPC对肢体I／R继发的肝组织损伤的保护作用可能是通过对NO／ET-1系统的调节作用而介导的,此时内皮源的NO产生增加,非内皮源的NO产生减少。     

逆转录病毒介导诱导型一氧化氮合酶基因转染抑制血管平滑肌细胞增殖的研究

目的：研究逆转录病毒介导诱导型一氧化氮合酶（iNOS）基因转染对体外培养的大鼠主动脉血管平滑肌细胞（VSMC）增殖的影响,探讨iNOS转基因治疗血管移植术后再狭窄的可行性。方法：将不同滴度的病毒上清转染体外培养的VSMC;采用RT-PCR、Western-blot检测VSMC内iNOSmRNA和iNOS蛋白的表达;用Griess法检测iNOS转基因细胞的培养液中一氧化氮（NO）的含量;用改良MTT、法检测iNOS转基因对VSMC增殖的抑制作用。结果：不同滴度的PLXSNiNOS转染体外培养的VSMC48h后,在VSMC内可检测到外源性iNOSmRNA和iNOS蛋白,表达水平随病毒滴度的增加而增强,呈现剂量依赖性;而用最高滴度的PIXSN转染体外培养的VSMC48h后,在VSMC内未能检测到外源性iNOSmRNA和iNOS蛋白表达;iNOS转基因细胞的培养液中NO含量显著增高,同时VSMC增殖受到明显抑制,均呈现剂量依赖性。结论：逆转录病毒介导iNOS基因可高效转染体外培养的VSMC,并在细胞内表达活性的iNOS蛋白,而且产生大量的NO,明显抑制VSMC增殖。为iNOS转基因治疗血管移植术后再狭窄的临床应用提供有力的实验依据。     

内、外源性硫化氢在脂多糖所致大鼠急性肺损伤中的作用

目的：探讨内、外源性硫化氢（H2S）在脂多糖（LPS）所致大鼠急性肺损伤（ALI）中的作用并初探其机制。方法：将120只SD大鼠随机分为对照组、IPS组（经气管内滴注LPS复制ALI模型）、NaHS＋LPS组和炔丙基甘氨酸（PPG）＋LPS组。给药后4h或8h处死动物,测定肺系数;光镜观察肺组织形态学改变;化学法检测血浆H2S、NO和CO含量、肺组织丙二醛（MDA）含量、胱硫醚-γ-裂解酶（CSE）、诱导型一氧化氮合酶（iNOS）和血红素加氧酶（HO）活性以及支气管肺泡灌洗液（BALF）中中性粒细胞（PMN）数目和蛋白含量的变化;用免疫组织化学法检测肺组织iNOS、HO-1蛋白表达。再将血浆H2S含量与上述指标进行相关性分析。结果：气管内滴注LPS可引起肺组织明显的形态学改变;肺系数和肺组织MDA含量增加;BALF中PMN数目和蛋白含量增加;血浆H2S含量和肺组织CSE活性下降;肺组织iNOS活性、HO活性和iNOS蛋白表达、HO-1蛋白表达增强,血浆NO含量、CO含量增加。预先给予NaHS可显著减轻LPS所致上述指标的改变;而预先给予PIG可加重LPS所致肺损伤,使BALF中PMN数目和蛋白含量、血浆NO含量、肺组织iNOS活性和iNOS蛋白表达进一步增加,但对血浆CO含量、肺组织HO活性和HO-1蛋白表达无明显影响。HS含量与CSE活性、血浆CO含量、肺组织HO-1活性呈正相关（r值=0．945—0．987,P均〈0．01）;与其他指标呈负相关（r值=-0．994～-0．943,P均〈0．01）。结论：H2S／CSE体系的下调在LPS所致大鼠Ⅲ的发病学中有一定作用,内、外源性H2S具有抗LPS所致Au的作用,该作用可能与其抗氧化效应、减轻PMN所致肺过度的炎症反应以及下调NO／iNOS体系、上调CO／HO—1体系有一定关系。     

Nitric oxide

Nitric oxide (NO)--a 1:1 combination of the two most abundant gaseous elements--is a biological mediator of complexity, subtlety and protean effects. The history of its discovery as a mediator is fascinating, and its role in mammalian biology and medicine is proving to be of fundamental importance.     

Nitric oxide and nitric oxide synthase activity in plants

Research on NO in plants has gained considerable attention in recent years mainly due to its function in plant growth and development and as a key signalling molecule in different intracellular processes in plants. The NO emission from plants is known since the 1970s, and now there is abundant information on the multiple effects of exogenously applied NO on different physiological and biochemical processes of plants. The physiological function of NO in plants mainly involves the induction of different processes, including the expression of defence-related genes against pathogens and apoptosis/programmed cell death (PCD), maturation and senescence, stomatal closure, seed germination, root development and the induction of ethylene emission. NO can be produced in plants by non-enzymatic and enzymatic systems. The NO-producing enzymes identified in plants are nitrate reductase, and several nitric oxide synthase-like activities, including one localized in peroxisomes which has been biochemically characterized. Recently, two genes of plant proteins with NOS activity have been isolated and characterized for the first time, and both proteins do not have sequence similarities to any mammalian NOS isoform. However, different evidence available indicate that there are other potential enzymatic sources of NO in plants, including xanthine oxidoreductase, peroxidase, cytochrome P450, and some hemeproteins. In plants, the enzymatic production of the signal molecule NO, either constitutive or induced by different biotic/abiotic stresses, may be a much more common event than was initially thought.     

Multimodality imaging of nitric oxide and nitric oxide synthases

Nitric oxide (NO) and NO synthases (NOSs) are crucial factors in many pathophysiological processes such as inflammation, vascular/neurological function, and many types of cancer. Noninvasive imaging of NO or NOS can provide new insights in understanding these diseases and facilitate the development of novel therapeutic strategies. In this review, we will summarize the current state-of-the-art multimodality imaging in detecting NO and NOSs, including optical (fluorescence, chemiluminescence, and bioluminescence), electron paramagnetic resonance (EPR), magnetic resonance (MR), and positron emission tomography (PET). With continued effort over the last several years, these noninvasive imaging techniques can now reveal the biodistribution of NO or NOS in living subjects with high fidelity which will greatly facilitate scientists/clinicians in the development of new drugs and/or patient management. Lastly, we will also discuss future directions/applications of NO/NOS imaging. Successful development of novel NO/NOS imaging agents with optimal in vivo stability and desirable pharmacokinetics for clinical translation will enable the maximum benefit in patient management.     

Production of nitrogen oxide and dinitrogen oxide by autotrophic nitrifiers

Autotrophic nitrifiers have been shown to produce nitrogen oxide and dinitrogen oxide under oxic conditions. Dinitrogen oxide is produced mainly during nitrite reduction (i.e. aerobic denitrification) whereas nitrogen oxide is produced during both aerobic denitrification and as a result of chemodenitrification. Oxygen is the single most influential environmental factor affecting the production of nitrogen and dinitrogen oxides; a decrease in oxygen can result in a several-fold increase in nitrogen oxide and dinitrogen oxide production. Emission of nitrogen oxide and dinitrogen oxide from wastewater treatment plants and fertilized soils is well documented; however, only recently have the contributions from such environments to the global nitrogen and dinitrogen oxide budget been considered.     

Nitric oxide donors

Nitric oxide (NO) donors are pharmacologically active substances that release NO in vivo or in vitro. NO has a variety of functions such as the release of prostanoids, inhibition of platelet aggregation, effect on angiogenesis, and production of oxygen free radicals. This report discusses the chemical and pharmacological characteristics of NO donors, their effect on platelet function and cyclooxygenase, their cardiac action including myocardial infarction, and release of superoxide anions. This review stresses NO tolerance and the effect of NO donors on angiogenesis in myocardial infarction and in solid tumors.